Gedeon Richter’s Q1 Hit By Weak Ruble But Expects More M&A In Q2

Further Biotechnology And Women’s Health Expansion Expected In 2024

 
• By Urtė Fultinavičiūtė
  
Q1 And Q2 written on a dice
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business